Advertisement
Singapore markets open in 3 hours 56 minutes
  • Straits Times Index

    3,314.14
    +8.12 (+0.25%)
     
  • S&P 500

    5,447.87
    -16.75 (-0.31%)
     
  • Dow

    39,411.21
    +260.88 (+0.67%)
     
  • Nasdaq

    17,496.82
    -192.54 (-1.09%)
     
  • Bitcoin USD

    59,553.55
    -4,192.38 (-6.58%)
     
  • CMC Crypto 200

    1,231.93
    -77.79 (-5.94%)
     
  • FTSE 100

    8,281.55
    +43.83 (+0.53%)
     
  • Gold

    2,346.50
    +15.30 (+0.66%)
     
  • Crude Oil

    81.74
    +1.01 (+1.25%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • Nikkei

    38,804.65
    +208.18 (+0.54%)
     
  • Hang Seng

    18,027.71
    -0.81 (-0.00%)
     
  • FTSE Bursa Malaysia

    1,589.66
    -0.71 (-0.04%)
     
  • Jakarta Composite Index

    6,889.17
    -6,879.98 (-49.97%)
     
  • PSE Index

    6,272.46
    +113.98 (+1.85%)
     

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif., May 29, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in two upcoming investor conferences.

CareDx’s management is scheduled to present at the:

  • Jefferies Global Healthcare Conference on Thursday, June 6, 2023, at 11:30 AM PT / 2:30 PM ET.

  • Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2023, at 1:00 PM PT / 4:00 PM ET.

ADVERTISEMENT

To listen to the webcast, please visit the Events & Presentations section of CareDx’s Investor Relations website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529027582/en/

Contacts

CareDx, Inc.
Media Relations
Anna Czene
818-731-2203
aczene@caredx.com

Investor Relations
Greg Chodaczek
Investor@caredx.com